Aptose Biosciences
APTO
1,48 €
Share price
0.00%
Change (1 day)
180.02%
Change (1 year)
Categories
Operating Margin for Aptose Biosciences (APTO)
Operating Margin as of July 2025 (TTM): -4,324.23%
According to Aptose Biosciences's latest financial reports and stock price the company's current Operating Margin is -4,324.23%. At the end of 2010 the company had an Operating Margin of -4,345.04%.
Operating Margin history for Aptose Biosciences from 2001 to 2010
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2010 | -4,345.04% | 11.57% |
| 2009 | -3,894.57% | -84.73% |
| 2008 | -25,511.63% | 234.62% |
| 2007 | -7,623.98% | -87.87% |
| 2006 | -62,858.09% | -81.96% |
| 2005 | -348,485.48% | 6624.21% |
| 2004 | -5,182.55% | -119.05% |
| 2003 | 27,201.89% | |
| 2001 | -1,177,628.74% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Advaxis ADXS | -399,877.00% | 9,147.36% | 🇺🇸 USA |
 Corbus Pharmaceuticals
CRBP | -5,176.38% | 19.71% | 🇺🇸 USA |
 ImmunoGen
IMGN | -203.81% | -95.29% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.